James M. Angelastro
Affiliations: | University of California, Davis, Davis, CA |
Area:
Neuroscience Biology, PharmacologyGoogle:
"James Angelastro"Mean distance: 53433
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Banerjee D, Bobolla S, Okochi S, et al. (2023) Activating Transcription Factor 5 (ATF5) Promotes Neuroblastoma Metastasis by Inducing Anoikis Resistance. Cancer Research Communications |
| Hua ZY, Hansen JN, He M, et al. (2020) PRMT1 promotes neuroblastoma cell survival through ATF5. Oncogenesis. 9: 50 |
| Sun X, Jefferson P, Zhou Q, et al. (2019) Dominant-Negative ATF5 Compromises Cancer Cell Survival by Targeting CEBPB and CEBPD. Molecular Cancer Research : McR |
| Allen SA, Datta S, Sandoval J, et al. (2019) Cetylpyridinium chloride is a potent AMP-activated kinase (AMPK) inducer and has therapeutic potential in cancer. Mitochondrion |
| Sun X, Angelastro JM, Merino D, et al. (2019) Dominant-negative ATF5 rapidly depletes survivin in tumor cells. Cell Death & Disease. 10: 709 |
| Sears TK, Datta S, Cortopassi G, et al. (2019) Abstract 3846: Targeting epigenetic dysregulation in isocitrate dehydrogenase mutant glioblastoma Cancer Research. 79: 3846-3846 |
| Sears TK, Angelastro JM. (2017) The transcription factor ATF5: role in cellular differentiation, stress responses, and cancer. Oncotarget. 8: 84595-84609 |
| Angelastro JM. (2017) Targeting ATF5 in Cancer. Trends in Cancer. 3: 471-474 |
| Wald JH, Hatakeyama J, Printsev I, et al. (2017) Suppression of planar cell polarity signaling and migration in glioblastoma by Nrdp1-mediated Dvl polyubiquitination. Oncogene. 36: 5158-5167 |
| York D, Sproul CD, Chikere N, et al. (2017) Expression and targeting of transcription factor ATF5 in dog gliomas. Veterinary and Comparative Oncology |